Aspen Neuroscience, Inc.

Aspen Neuroscience, Inc. company information, Employees & Contact Information

Aspen is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical need, beginning with autologous neuron replacement for Parkinson’s disease (PD) and extending across the brain and affected organs.
Looking for a particular Aspen Neuroscience, Inc. employee's phone or email?

Aspen Neuroscience, Inc. Questions

News

Aspen Neuroscience Advances Parkinson's Disease Therapy with Cohort 3 Initiation - SynBioBeta

Aspen Neuroscience Advances Parkinson's Disease Therapy with Cohort 3 Initiation SynBioBeta

Aspen Neuroscience Initiates Cohort 3 in ASPIRO Phase 1/2a Trial, Highlighting Commercial Formulation of ANPD001 and Its Transformative Potential for Parkinson's Disease - PR Newswire

Aspen Neuroscience Initiates Cohort 3 in ASPIRO Phase 1/2a Trial, Highlighting Commercial Formulation of ANPD001 and Its Transformative Potential for Parkinson's Disease PR Newswire

Aspen Neuroscience to Present at the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting - PR Newswire

Aspen Neuroscience to Present at the International Society for Stem Cell Research (ISSCR) 2025 Annual Meeting PR Newswire

Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s Disease - Business Wire

Mytos Announces Manufacturing Collaboration with Aspen Neuroscience in Parkinson’s Disease Business Wire

Aspen Neuroscience Announces Completion of First and Second Cohorts in ASPIRO Phase 1/2a Trial for Parkinson's Disease - PR Newswire

Aspen Neuroscience Announces Completion of First and Second Cohorts in ASPIRO Phase 1/2a Trial for Parkinson's Disease PR Newswire

Parkinson Disease iPSC-derived Therapy ANPD001 Cleared for Clinical Trial in the US - CGTLive®

Parkinson Disease iPSC-derived Therapy ANPD001 Cleared for Clinical Trial in the US CGTLive®

Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer - PR Newswire

Dalen Meeter Joins Aspen Neuroscience as Chief Financial Officer PR Newswire

Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson's Disease - PR Newswire

Aspen Neuroscience Announces 6-Month ASPIRO Phase 1/2a Clinical Trial Results of Personalized Cell Therapy for Parkinson's Disease PR Newswire

Aspen Neuroscience Appoints Ana Sousa Chief Regulatory Officer - PR Newswire

Aspen Neuroscience Appoints Ana Sousa Chief Regulatory Officer PR Newswire

Aspen Neuroscience Announces First Patient Dosed in First-in-Human Phase 1/2a Clinical Trial of Autologous Neuronal Cell Replacement Therapy for Parkinson's Disease - PR Newswire

Aspen Neuroscience Announces First Patient Dosed in First-in-Human Phase 1/2a Clinical Trial of Autologous Neuronal Cell Replacement Therapy for Parkinson's Disease PR Newswire

Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting - PR Newswire

Aspen Neuroscience to Present at International Society for Cell & Gene Therapy (ISCT) Annual Meeting PR Newswire

Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead - PR Newswire

Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead PR Newswire

Aspen Neuroscience Announces Collaboration and License Agreement with Cell X Technologies - PR Newswire

Aspen Neuroscience Announces Collaboration and License Agreement with Cell X Technologies PR Newswire

Aspen Neuroscience Announces Management Transition - PR Newswire

Aspen Neuroscience Announces Management Transition PR Newswire

Aspen Neuroscience Announces Expansion of Autologous Cell Therapy Manufacturing in San Diego - PR Newswire

Aspen Neuroscience Announces Expansion of Autologous Cell Therapy Manufacturing in San Diego PR Newswire

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons - PR Newswire

Parkinson's Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients' Own Autologous Replacement Neurons PR Newswire

Aspen Neuroscience Announces Appointment of Damien McDevitt, PhD as President and Chief Executive Officer - PR Newswire

Aspen Neuroscience Announces Appointment of Damien McDevitt, PhD as President and Chief Executive Officer PR Newswire

Aspen Neuroscience Announces Promotion of Andres Bratt-Leal, PhD, to Senior Vice President of Research & Development - PR Newswire

Aspen Neuroscience Announces Promotion of Andres Bratt-Leal, PhD, to Senior Vice President of Research & Development PR Newswire

CMC Expert Kim Raineri Joins Aspen Neuroscience as Chief Technology Officer - PR Newswire

CMC Expert Kim Raineri Joins Aspen Neuroscience as Chief Technology Officer PR Newswire

Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer - PR Newswire

Industry Veteran Kameel Farag Joins Aspen Neuroscience as Chief Financial Officer PR Newswire

Caryn Peterson Joins Aspen Neuroscience Board of Directors - PR Newswire

Caryn Peterson Joins Aspen Neuroscience Board of Directors PR Newswire

Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners - PR Newswire

Aspen Neuroscience Announces $147.5 Million Series B Financing, Led by GV, LYFE Capital and Revelation Partners PR Newswire

Aspen Neuroscience Cofounder Dr. Andrés Bratt-Leal Receives 2023 Biocom California Life Science Catalyst Award - PR Newswire

Aspen Neuroscience Cofounder Dr. Andrés Bratt-Leal Receives 2023 Biocom California Life Science Catalyst Award PR Newswire

Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease - PR Newswire

Aspen Neuroscience Launches With $6.5 Million Seed Funding to Advance First-of-its-Kind Personalized Cell Therapy for Parkinson's Disease PR Newswire

Cell X Technologies and Aspen Neuroscience collaborate to address throughput and scalability in manufacturing automation to facilitate iPSC cell processing. - PR Newswire

Cell X Technologies and Aspen Neuroscience collaborate to address throughput and scalability in manufacturing automation to facilitate iPSC cell processing. PR Newswire

Scientific Leader Xiaokui Zhang, Ph.D. Joins Aspen Neuroscience as Chief Scientific Officer - PR Newswire

Scientific Leader Xiaokui Zhang, Ph.D. Joins Aspen Neuroscience as Chief Scientific Officer PR Newswire

Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease - PR Newswire

Aspen Neuroscience Announces $70 Million Series A Financing Led by OrbiMed to Advance Development of the First Autologous Neuron Replacement Therapy to Treat Parkinson Disease PR Newswire

Aspen Neuroscience, underway with Parkinson's cell therapy trial, bolsters manufacturing with new San Diego facility - Fierce Pharma

Aspen Neuroscience, underway with Parkinson's cell therapy trial, bolsters manufacturing with new San Diego facility Fierce Pharma

How Aspen Neuroscience is transforming iPSC research for Parkinson’s disease - SelectScience

How Aspen Neuroscience is transforming iPSC research for Parkinson’s disease SelectScience

Aspen Partners with Mytos to Automate Stem Cell Production for Parkinson’s Therapy - Genetic Engineering and Biotechnology News

Aspen Partners with Mytos to Automate Stem Cell Production for Parkinson’s Therapy Genetic Engineering and Biotechnology News

BlueRock Therapeutics' Parkinson Disease Cell Therapy Bemdaneprocel Shows Initial Efficacy in Phase 1 Trial - CGTLive®

BlueRock Therapeutics' Parkinson Disease Cell Therapy Bemdaneprocel Shows Initial Efficacy in Phase 1 Trial CGTLive®

Investors take root in Aspen Neuroscience's customized cell therapy as $147.5M round closes - Fierce Biotech

Investors take root in Aspen Neuroscience's customized cell therapy as $147.5M round closes Fierce Biotech

Aspen starts phase 1 stem cell transplant clinical trial - Cure Parkinson's

Aspen starts phase 1 stem cell transplant clinical trial Cure Parkinson's

Top Aspen Neuroscience, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant